Entrada Therapeutics Inc (TRDA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $12.79
• Market Cap: $438.76M
• EPS: $-2.57
• 52-Week High: $12.33
• 52-Week Low: $4.93

Market Sentiment

Entrada Therapeutics Inc currently has a Neutral sentiment score of 0.12.

About Entrada Therapeutics Inc

None

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Entrada Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TRDA pay dividends?

Entrada Therapeutics Inc (TRDA) does not currently pay a regular dividend.

What is TRDA's market cap?

Entrada Therapeutics Inc (TRDA) has a market capitalization of $438.76M with a current stock price of $12.79.